0001104659-21-094094.txt : 20210720 0001104659-21-094094.hdr.sgml : 20210720 20210720193413 ACCESSION NUMBER: 0001104659-21-094094 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210719 FILED AS OF DATE: 20210720 DATE AS OF CHANGE: 20210720 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Islam Saqib CENTRAL INDEX KEY: 0001575408 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39044 FILM NUMBER: 211102331 MAIL ADDRESS: STREET 1: ALEXION PHARMACEUTICALS STREET 2: 352 KNOTTER DRIVE CITY: CHESHIRE STATE: CT ZIP: 06410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SpringWorks Therapeutics, Inc. CENTRAL INDEX KEY: 0001773427 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 BUSINESS PHONE: 203-883-9490 MAIL ADDRESS: STREET 1: 100 WASHINGTON BOULEVARD CITY: STAMFORD STATE: CT ZIP: 06902 4 1 tm2122747-1_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-07-19 0 0001773427 SpringWorks Therapeutics, Inc. SWTX 0001575408 Islam Saqib C/O SPRINGWORKS THERAPEUTICS, INC., 100 WASHINGTON BLVD. STAMFORD CT 06902 1 1 0 0 Chief Executive Officer Common Stock 2021-07-19 4 S 0 43928 76.0890 D 840124 D Common Stock 2021-07-20 4 S 0 18572 77.6842 D 821552 D The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.05 to $77.38, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $75.90 to $79.23, inclusive. /s/ Francis I. Perier, Jr as Attorney-in-Fact 2021-07-20